AI Summary & Key Takeaways
AI InsightOverall and disease free survival rate were not evaluated because of short follow up time.
📌 3 Key Takeaways
Abstract
In this retrospective analysis, according to the diagnostic and therapeutic parameters, we evaluated 245 breast cancer patients who had postoperative adjuvant radiotherapy in the Radiation Oncology Department of Ankara Oncology Hospital between January 1995-December 1999. While 214 patients (%87) were given adjuvant chemotherapy with radiotherapy, 35 patients at stage III B were become operable with neoadjuvant chemotherapy. Adjuvant hormonotherapy were given to 70 patients (%29). As 24 of them (%10) were given only hormonotherapy, 46 patients (%19) were given hormonotherapy and chemotherapy. In the mean follow-up time of 33 months, there were 5 patients (%2) with locoregional recurrence and 35 patients (%14) with distant metastasis. Overall and disease free survival rate were not evaluated because of short follow up time.
Özet
Bu retrospektif analizde Ankara Onkoloji Hastanesi Radyasyon Onkolojisi Kliniğinde Ocak 1995 - Aralık 1999 yılları arasında postoperatif adjuvant radyoterapi programına alınan operable meme kanserli 245 hasta tanı ve tedavi parametrelerine göre değerlendirilmiştir. Hastalardan 214' üne (%87) radyoterapiyle birlikte adjuvant kemoterapi ugulanırken evre III B olan 35 hasta neoadjuvant kemoterapiyle operable sınıra çekilmiştir. Adjuvant hormonoterapi verilen hasta sayısı 70 (%29) olup 24 (%10) hastaya tek başına 46 (%19) hastaya da kemoterapiyle birlikte hormonoterapi verilmiştir Ortalama 33 aylık izlem süresince 5 hastada(%2) lokal-bölgesel nüks 35 hastada da(%14) uzak yayılım görülmüştür. İzlem süresinin yetersiz olması nedeni ile overall ve hastalıksız sağkalım süreleri değerlendirilememiştir.